• LAST PRICE
    3.5244
  • TODAY'S CHANGE (%)
    Trending Up0.4644 (15.1765%)
  • Bid / Lots
    3.5200/ 21
  • Ask / Lots
    3.5700/ 1
  • Open / Previous Close
    3.2000 / 3.0600
  • Day Range
    Low 3.1900
    High 3.6500
  • 52 Week Range
    Low 2.1450
    High 5.1300
  • Volume
    388,654
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.06
TimeVolumeANIX
09:32 ET169033.2
09:33 ET51573.28
09:35 ET74523.3
09:37 ET65093.35
09:39 ET55693.35
09:42 ET78793.36
09:44 ET16603.37
09:46 ET3823.36
09:48 ET18253.38
09:50 ET32613.46
09:51 ET120003.47
09:53 ET283043.3766
09:55 ET2003.37
09:57 ET3003.38
10:00 ET42003.34
10:02 ET38753.25
10:06 ET117503.2615
10:08 ET184573.36
10:09 ET225543.35
10:11 ET1003.5
10:13 ET63963.47
10:15 ET15423.45
10:20 ET1003.42
10:22 ET1003.36
10:24 ET102003.4
10:26 ET94703.4799
10:27 ET34863.4
10:29 ET1003.38
10:31 ET33333.4699
10:33 ET118043.583
10:36 ET67613.6
10:38 ET69543.64
10:40 ET38913.61
10:42 ET71113.535
10:44 ET2503.5817
10:45 ET45413.54
10:47 ET1003.54
10:49 ET10003.535
10:54 ET2003.535
10:56 ET69143.5654
10:58 ET5983.52
11:00 ET3503.47
11:03 ET58253.5
11:05 ET24563.54
11:07 ET95813.548
11:09 ET3103.5639
11:12 ET11803.58
11:14 ET39803.565
11:16 ET48013.57
11:18 ET1003.58
11:20 ET10003.6
11:21 ET146173.53
11:23 ET13003.59
11:25 ET106443.51
11:30 ET2003.57
11:32 ET53763.515
11:34 ET52003.49
11:36 ET72883.48
11:38 ET5003.5
11:39 ET5003.4873
11:41 ET24803.48
11:43 ET22503.48
11:45 ET61053.5
11:48 ET68533.5244
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesANIX
Anixa Biosciences Inc
98.5M
-9.0x
---
United StatesGUTS
Fractyl Health Inc
98.7M
-1.5x
---
United StatesLPTX
Leap Therapeutics Inc
98.7M
-1.3x
---
United StatesIMUX
Immunic Inc
100.0M
-0.9x
---
United StatesMIST
Milestone Pharmaceuticals Inc
98.5M
-2.3x
---
United StatesMNOV
MediciNova Inc
98.1M
-9.8x
---
As of 2024-11-22

Company Information

Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.

Contact Information

Headquarters
3150 Almaden Expy Ste 250SAN JOSE, CA, United States 95118
Phone
408-708-9808
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer
Amit Kumar
President, Chief Financial Officer, Chief Operating Officer, Company Secretary
Michael Catelani
Lead Independent Director
Lewis Titterton
Independent Director
Arnold Baskies
Independent Director
Emily Gottschalk

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$98.5M
Revenue (TTM)
$0.00
Shares Outstanding
32.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.82
EPS
$-0.39
Book Value
$0.78
P/E Ratio
-9.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.